Veriheal

AUGUST 31, 2020

It brings us great pleasure to present the 10 winners of Veriheal’s Innovation in Cannabis Scholarship 2020. Veriheal’s Innovation in Cannabis Scholarship 2020 Winners . Nishtha Tripathi. Essay: “Integrating Research and Medicine: Cannabis Related Treatment for Neurodegenerative Diseases”. School: George Washington University.

Research and Development 117

Research and Development Education Agriculture Patients 117

MedicalJane

JUNE 12, 2020

Of the 1,276 participants, 524 adult patients and 284 adult caregivers of children or dependent adults, all self-reported using cannabis for medicinal purposes. The control group consisted of 271 adult patients who were considering cannabis use, and 197 adult caregivers who were considering it for a dependent child or adult patient.

Chronic Pain 145

Chronic Pain Epilepsy Patients Medicine 145

Cannabis Law Report

NOVEMBER 2, 2021

This updated edition reviews over 450 peer-reviewed studies assessing the safety and efficacy of either whole-plant cannabis or individual cannabinoids in 23 different patient populations, including autism , chronic pain , diabetes , fibromyalgia , migraine , and post-traumatic stress.

Safety 52

Safety Patients Chronic Pain Advocacy 52

Healer

MARCH 26, 2021

That is, until a “forward-thinking” primary care physician suggested medical cannabis for his chronic pain, which Gresh, 54, said set him on a new path that has changed his life for the better and helped him stop using virtually all drugs classified as highly addictive. . “I It’s estimated that 2020 spending was about $48 million. .

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

SpeedWeed

APRIL 3, 2021

A new survey out of Texas reveals that, according to the data they gathered, 61 percent of the state’s medical cannabis users turn to medical cannabis as a replacement for prescription drugs. . The survey was conducted online between August 11, 2020, and October 6, 2020, and recruited participants through medical cannabis patient networks.

Patients 52

Patients Chronic Pain Policy History 52

Veriheal

MAY 31, 2022

According to data released by the Centers for Disease Control and Prevention , there were an estimated 2,620 opioid overdose deaths in Texas between Aug. 1, 2020, and July 31, 2021—a 43% increase from the same period a year before. For too long, America has relied too heavily on opioids for pain relief. The Opioid Problem.

Programs 52

Programs Chronic Pain Treatment Conditions 52

TheAnswerPage

JULY 10, 2022

In 2020, PTSD was the second most common for medical cannabis licensure. According to an analysis of data from U.S. medical cannabis registries through 2016, chronic pain was the most common reason for medical cannabis licensure (64.5%), followed by multiple sclerosis (14.4%), and nausea or vomiting (6.2%).

Chronic Pain 52

Chronic Pain Conditions Data Patients 52

Cannabis Law Report

JANUARY 3, 2022

According to the amendment to the law on addictive substances and drugs, which came into force on January 1, doctors will now only prescribe medical marijuana to their patients electronically. Almost 200 doctors throughout the Czech Republic are currently prescribing therapeutic cannabis to some of their patients. Source: CTK.

Media 52

Media Chronic Pain Patients Treatment 52

Cannabis Law Report

AUGUST 24, 2022

The third Cannabis as Medicine Survey (CAMS20) follows on from CAMS16 and CAMS18, and includes 1,600 people using medical cannabis between September 2020 and January 2021. These include safer routes of administration, greater certainty of access, and better communication between patients and doctors.

Medicine 52

Medicine Legalization Chronic Pain Access 52

SpeedWeed

MARCH 6, 2021

Forcing patients to purchase more. Doing so, Pollara wrote, would effectively force a 50% to 150% tax on patients. It is also the one which produces the most and strongest medicinal effects for patients. Patients will feel the effects of THC caps almost immediately,” Pollara added. Revival of cap bills in 2020.

THC 52

THC Patients Law Chronic Pain 52

Canna Care Docs

DECEMBER 16, 2020

Between the pandemic and the political climate, 2020 hasn’t exactly been a walk in the park. The difference is that medical patients may have access to higher dosages, among other benefits depending on their state, and receive a higher level of service to match them with the best products for their symptoms. Chronic pain.

Chronic Pain 52

Chronic Pain Marijuana Clinical Trials Epilepsy 52

SpeedWeed

MARCH 9, 2021

Chronic Pain Targeted. Eelco Ockers, Head of Stada, said it wants to focus primarily on the ‘indications of chronic pain , neurology and oncology ‘and that it had been observing the medical cannabis market for some time.

Chronic Pain 52

Chronic Pain Business Pharmaceutical Extraction 52

Puff Puff Post

MARCH 2, 2020

NEWS FROM KHIRON LIFE SCIENCES CORP. · Further to cultivation quotas announced on February 26, 2020, this authorization by the Colombian Technical Quotas Authority (“TQG”) allows the Company to now produce oils for sale both domestically and abroad. · Of the 9.3

Extraction 52

Extraction THC Chronic Pain Cultivation 52

Veriheal

FEBRUARY 10, 2022

Medical cannabis patient enrollment is on the rise in South Dakota, and what better way to stay on top of things than by introducing a cloud-based platform? South Dakota voters approved Initiated Measure 26 in November 2020, which effectively legalized medical cannabis across the state. Med Card Registration via Cloud-based Registry.

Programs 52

Programs Chronic Pain Patients Conditions 52

Cannabis Law Report

MAY 10, 2022

First academic study of national medicinal cannabis data. Using data from the Therapeutic Goods Administration (TGA) – Australia’s Special Access Scheme B, the researchers found the other two top reasons for prescriptions were pain and sleep disorders. Here’s the Uni of Sydney press release. 11 May 2022.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Veriheal

DECEMBER 28, 2021

This is according to recent data from a report published by Market Research Future (MRT) – a pioneer in market analysis. Chronic pain. The year 2020 served as a major stepping stone for the North American medical cannabis market which, by that point, was already well-established. Amyotrophic lateral sclerosis (ALS).

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

Puff Puff Post

MARCH 2, 2020

NEWS FROM KHIRON LIFE SCIENCES CORP. · Further to cultivation quotas announced on February 26, 2020, this authorization by the Colombian Technical Quotas Authority (“TQG”) allows the Company to now produce oils for sale both domestically and abroad. · Of the 9.3

Extraction 40

Extraction THC Chronic Pain Cultivation 40

Cannabis Law Report

NOVEMBER 9, 2021

KWC has been operating profitably and expanding significantly with 2020 revenues in excess of USD$3.5MM, on track for USD$4.5MM in 2021. Delic has been focused on opening locations in secondary cities with considerable demand, in an effort to provide access to the most patients. experience and knowledge to Delic. Transaction Summary.

Treatment 52

Treatment Therapy Media Access 52

Puff Puff Post

JANUARY 1, 2020

Cancer patients suffer not only from cancer, but the damaging effects of treatment. Doctors prescribe various forms of opiods to cancer patients for pain. At other times cannabis treats the pain of cancer patients better. Cannabinoids even alleviate certain types of pain that opiates don’t always treat well.

Treatment 64

Treatment Clinical Trials Research and Development Cannabinoids 64

Cannabis Law Report

DECEMBER 14, 2021

The products launched under its flagship medical Ceed brand and are comprised of four formulations that will be available for patients throughout the UK when prescribed by a specialist consultant. Columbia Care’s mission has always been to provide patients with access to the highest quality, safest medicinal cannabis products available.

Extraction 52

Extraction Patients Medicine Tincture 52

Puff Puff Post

JANUARY 1, 2020

Cancer patients suffer not only from cancer, but the damaging effects of treatment. Doctors prescribe various forms of opiods to cancer patients for pain. At other times cannabis treats the pain of cancer patients better. Cannabinoids even alleviate certain types of pain that opiates don’t always treat well.

Treatment 40

Treatment Clinical Trials Research and Development Cannabinoids 40

Kind Meds (Cannabis Education Blog)

MARCH 9, 2022

Accidental Acute Cannabis Intoxication Presenting as Seizure in Pediatrics Patients. This can be a great tool for parents who suffer from conditions like chronic pain, anxiety, and depression. [3] Cannabis use, employment, and income: fixed-effects analysis of panel data. 2] Emoto, J., Weeks, K., & Kallail, K.

Digestion 98

Digestion Consumption Cannabis Recreational 98

Veriheal

OCTOBER 5, 2020

The program requires cannabis patients to have a licensed physician to certify that the individual would benefit from medical cannabis before they can register for it. The Hawaiian cannabis regulations also allow caregivers to take on the responsibility for managing the cannabis consumption and cultivation of the cannabis qualifying patient.

Edibles 52

Edibles Legalization Decriminalization Consumption 52

Cannabis Law Report

FEBRUARY 17, 2020

I am a legal Florida medical marijuana patient since January 2017, as well as a traveling medical cannabis writer, patient educator and vocal advocate. I am a legal Florida medical marijuana patient since January 2017, as well as a traveling medical cannabis writer, patient educator and vocal advocate.

Dispensary 76

Dispensary Patients Agriculture Conditions 76

Cannabis Law Report

MARCH 19, 2020

18 March 2020. Last week, FDA issued its report to the US House Committee on Appropriations and the US Senate Committee on Appropriations entitled “Cannabidiol (CBD) Report in Response to Further Consolidated Appropriations Act, 2020 U.S. by Raqiyyah Pippins , Bryant M. Godfrey , Evelina J. Arnold & Porter.

CBD 45

CBD Research and Development Seed-To-Sale Data 45

Kind Meds (Cannabis Education Blog)

FEBRUARY 24, 2022

Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic … Continue reading , no one can honestly say every strain, cannabinoid and terpene causes the same result: laziness. The journal of headache and pain , 19 (1), 1-28. Moscowitz, L.,

Marijuana 52

Marijuana Research and Development Sleep Strains 52

Healer

APRIL 5, 2021

While there’s substantial human research that pharmaceutical combinations of CBD and THC can reduce pain, at the present time there’s much less data on CBD or CBD-dominant hemp products used alone for pain, but there are several small studies that suggest effectiveness, often at higher doses, according to Dr. Sulak.

CBD 98

CBD Chronic Pain Oil Topical 98

Healer

APRIL 5, 2021

While there’s substantial human research that pharmaceutical combinations of CBD and THC can reduce pain, at the present time there’s much less data on CBD or CBD-dominant hemp products used alone for pain, but there are several small studies that suggest effectiveness, often at higher doses, according to Dr. Sulak.

CBD 52

CBD Chronic Pain Oil Topical 52

Healer

APRIL 5, 2021

While there’s substantial human research that pharmaceutical combinations of CBD and THC can reduce pain, at the present time there’s much less data on CBD or CBD-dominant hemp products used alone for pain, but there are several small studies that suggest effectiveness, often at higher doses, according to Dr. Sulak.

CBD 52

CBD Chronic Pain Oil Topical 52

The Cannigma

FEBRUARY 14, 2021

Despite the traumatic brain injury, chronic pain, and years of PTSD, Otha Smith considers himself one of the lucky ones. Journaling can make cannabis use more mindful, deliberate and based on goals, past experiences, and your own personally cultivated data tracking what works best for you. Shutterstock).

Wellness and Beauty 145

Wellness and Beauty Data Terpenes Patients 145

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive. The states’ situation varies substantially.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

NOVEMBER 10, 2021

Envelta is Virpax’s endogenous enkephalin intranasal spray for acute and chronic pain, including pain associated with cancer. IND-enabling studies for Envelta are being performed under a Cooperative Research and Development Agreement (CRADA) with NCATS entered into by Virpax in August of 2020. “We

Research and Development 52

Research and Development Chronic Pain Pharmaceutical Clinical Trials 52

The Cannigma

FEBRUARY 14, 2021

Despite the traumatic brain injury, chronic pain, and years of PTSD, Otha Smith considers himself one of the lucky ones. Journaling can make cannabis use more mindful, deliberate and based on goals, past experiences, and your own personally cultivated data tracking what works best for you. Shutterstock).

Wellness and Beauty 73

Wellness and Beauty Data Terpenes Strains 73

Cannabis Law Report

NOVEMBER 15, 2021

Our lead product candidate is Envelta™, which utilizes MET to deliver enkephalin nanoparticles for acute and chronic pain including pain associated with cancer. FINANCIAL RESULTS FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2021 AND 2020. Three Months Ended September 30, 2021 and 2020. million.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

Cannabis Law Report

AUGUST 30, 2019

Ballot initiative campaigns to approve adult-use and medical cannabis, respectively, moved closer to appearing on the 2020 ballot in Arizona and Idaho, while a similar effort to put the issue of adult-use cannabis to Ohio voters has met with legal challenges from the State Election Board. Governor Ducey (R-AZ) opposes legalization.

Banking 45

Banking Research and Development Legislation Programs 45

Cannabis Law Report

NOVEMBER 22, 2019

Arizona regulators will stop issuing physical medical cannabis patient cards as of December 1 and will instead issue documents via email, that can be presented on a mobile phone or printed out. The state expects to issue its first license by the end of November and sales to begin by the end of the first quarter 2020.

Vaping 45

Vaping Research and Development Seed-To-Sale Hemp 45

Cannabis Law Report

OCTOBER 17, 2019

Some of the potential health benefits associated with THC and CBD, with and without the high, respectively, include reducing chronic pain such as from migraines or cancer, alleviating anxiety, reducing inflammation, and helping treat conditions such as epilepsy, PTSD, and glaucoma. billion in 2025, according to Grandview Research.

Law 40

Law Seed-To-Sale Hemp Recreational 40